Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) often produces results in underexpansion of the functional portion of transcatheter heart valve (THV) prostheses, particularly when these are deeply implanted, which leads to worse hemodynamics, a new study shows.